Fresh Insights

Digital Clinical Trial
September 3, 2019

Leveraging Digital Technology, Telemedicine, and Analytics to Transform Clinical Research

Digitalization of clinical trials will soon become the norm for pharma industry. In the industry’s ongoing quest to bring new...
Read More
July 31, 2019

Telemedicine: A promise of better outcomes or just connected care?

Up to 60% of the global population will suffer from chronic diseases such as heart failure, stroke, diabetes, blood pressure...
Read More
July 24, 2019

Innovations in Pharma Manufacturing: Current Trends and Future Outlook

Shifting demands, price and portfolio pressures are pushing pharma manufacturers to fast-track innovation Precision medicine is having a direct impact on...
Read More
April 22, 2019

To Deal Or Not To Deal: Lessons Learnt

The role of partnership in the pharmaceutical industry is ever increasing in realising the business goals. Our presentation provides a...
Read More
rare disease
March 6, 2019

Rare Disease Situation Analysis

Rare Disease Situation Analysis is aimed at providing a high level glimpse into the rare disease drug development and commercialization. Rare disease drug development has been an increasingly attractive proposition for biopharmaceutical companies.
Read More
May 25, 2018

Nanotechnology in Drug Discovery and Design

This presentation takes the reader on an exciting journey, about the Science beneath the development of Oncology Nano Drug delivery systems. How the tumor mico and macro environments throws conspicuous challenges to the nanotech field? Furthermore, the presentation also gives a sneak view of Nanotherapeutics clinical landscape across development strategies and tumors.
Read More
biosimilar caption
May 14, 2018

Biosimilar Clinical Development – A Strategic Lever?

The presentation gives some key insights on the emerging biosimilars developer landscape with focus on US, EU, China, Japan, South Korea, MENA and Indian markets. Furthermore, it provides a detailed analysis on Clinical differentiation of players for major products (Bevacizumab, Trastuzumab, Adalimumab, Rituximab, Infliximab and etanercept).
Read More
February 12, 2018

Key Considerations When Developing a DOAC – Part 3

The currently approved direct oral anti-coagulants have proven to be safe and efficacious in prevention of stroke in patients with AF. However, the choice of DOAC is influenced by several factors including specific patient characteristics (renal function etc.), preference of OD versus BID, physicians comfort with the drug and the cost of drug to the patient.
Read More
Entrepreneur Cafe
December 21, 2017

Entrepreneurship Opportunities for Millennials in Pharma

Indian start-up ecosystem has been steadily growing with over 5200 start-ups in the country today. India has become the world’s...
Read More
August 10, 2017

The Wearable Story – Part 1

The rapid consumer adoption of wearable devices for the collection of health data has inspired the next revolution in clinical trial operations. The integration of wearable health monitors with smartphones has opened up several fronts in clinical research. These integrated device-app-database systems can increase the frequency and accuracy of data collection, improve operational efficiencies, and achieve greater patient engagement in the clinical trial process.
Read More